Insider · CIK 0002039907
AI Upstream LLC
owner
Files at UPB (Upstream Bio, Inc.). First filing Oct 17, 2024, latest Oct 17, 2024.
Track record
Not enough history
Fewer than three past buys with six months of prices.
Median 6-month excess
-
after past buys, n = 0
Hit rate
-
past buys that beat the index over 6 months
Open-market trades
1 / 0
$20M bought, $0 sold
Signals
This insider’s open-market buys and sells, scored.
| Score | Side | Company | Value | Shares | Holdings change | Price context | Filed |
|---|---|---|---|---|---|---|---|
| 40Moderate | buy 310b5-1 | UPB Upstream Bio, Inc. | $20M | 1,175,000 | - | - |
Transactions
Every row this insider has filed, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Oct 15, 2024 | UPB Upstream Bio, Inc. | POpen-market purchase Common Stock10b5-1 | +1,175,000 | $17.00 | $20M | 1,175,000 | Oct 17, 2024 |
| Oct 15, 2024 | UPB Upstream Bio, Inc. | CConversion Common Stock10b5-1 | +3,147,000 | - | - | 4,322,000 | Oct 17, 2024 |
| Oct 15, 2024 | UPB Upstream Bio, Inc. | CConversion Common Stock10b5-1 | +1,172,410 | - | - | 5,494,410 | Oct 17, 2024 |
| Oct 15, 2024 | UPB Upstream Bio, Inc. | CConversion Series A Convertible Preferred Stockderivative10b5-1 | -3,147,000 | - | - | 0 | Oct 17, 2024 |
| Oct 15, 2024 | UPB Upstream Bio, Inc. | CConversion Series B Convertible Preferred Stockderivative10b5-1 | -1,172,410 | - | - | 0 | Oct 17, 2024 |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.